View from the Thoraxcenter: ESC 23 Late-breaking Science Wrap Up
-
Part 2 | Session 10 ARREST: Expedited Transfer to Cardiac Arrest Center for OHCA
-
Part 2 | Session 11 MULTISTARS AMI: Immediate vs Staged Revascularization in Acute MI
-
Part 2 | Session 12 2023 ESC Guidelines for the Management of ACS
-
Part 2 | Session 13 Meta-analysis of iFR-SWEDEHEART and DEFINE FLAIR
-
Part 2 | Session 14 FIRE: Complete or Culprit-Only PCI in Older Patients with MI
-
Part 2 | Session 15 NOTION: Nordic Aortic Valve Intervention
-
Part 2 | Session 2 ILUMIEN IV: OCT-Guided Stent vs Angiography
-
Part 2 | Session 3 OCTOBER: OCT vs Angiography for Complex Bifurcation PCI
-
Part 2 | Session 4 OCTIVUS: OCT-Guided vs IVUS-Guided PCI
-
Part 2 | Session 5 OCT Vs IVUS Vs Angiography Guidance
-
Part 2 | Session 6 HEART-FID: FCM in Heart Failure with Iron Deficiency
-
Part 2 | Session 7 ECLS-Shock: Extracorporeal Life Support in Cardiogenic Shock
-
Part 2 | Session 8 EARLY-UNLOAD: Early LA Septostomy vs Conventional Approach After VA-ECMO
Prof Nicolas Van Mieghem and Dr Joost Daemen discuss the new data from the STOPDAPT-3 trial (NCT04609111).
This study investigated whether prasugrel monotherapy without aspirin, compared to a 1-month dual therapy with aspirin and prasugrel, can reduce bleeding events after percutaneous coronary intervention (PCI) using cobalt-chromium everolimus-eluting stents (CoCr-EES, XienceTM) in patients with high bleeding risk or those with acute coronary syndrome.
What are the take-home messages from ESC 2O23?
Join us as we delve into the pivotal results that ignited debates and discussions at ESC Congress 2023. Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) return with their "View from the Thoraxcenter" review, where they analyse the hot line and late-breaking trials presented in Amsterdam.
In this ESC 2023 wrap-up, Prof Van Mieghem and Dr Daemen will dissect the data, evaluating real-world applicability, and distilling findings into actionable insights for clinical practice.
You can either opt to view the comprehensive wrap-up encompassing new data from 15 studies, or you may select and explore the specific studies that pique your interest.
More from this programme
Part 1
Complete Wrap Up
Part 2
ESC 23 Wrap Up by Studies
Faculty Biographies
Nicolas M Van Mieghem
Full Professor of Interventional Cardiology
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
Academic History
Prof. Nicolas M. Van Mieghem completed his medical training at the Catholic University of Leuven (Belgium), where he earned both his medical degree and his specialist degree in cardiology. During his time in Leuven, he developed a strong interest in cardiovascular medicine, particularly in the emerging field of minimally invasive cardiac interventions. After finishing his core medical and cardiology training, he pursued multiple advanced…
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Comments